We serve Chemical Name:methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate CAS:1234616-47-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate
CAS.NO:1234616-47-7
Synonyms:methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate
Molecular Formula:C9H7BrN2O2
Molecular Weight:255.06800
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.60000
Exact Mass:253.96900
LogP:1.88340
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate Use and application,methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate technical grade,usp/ep/jp grade.
Related News: he agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped. methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate manufacturer China considers self-ruled Taiwan to be part of its territory and has long sought to limit its diplomatic relations and recognition at international bodies such as the W.H.O. methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate supplier API and raw material are often confused due to the similar usage of the two terms. methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate vendor The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. methyl 3-bromoimidazo[1,2-a]pyridine-8-carboxylate factory he agency said the drugmaker and Emergent must agree that the FDA can share relevant information about the manufacturing of the doses with regulators where the vaccine is shipped.